The biotech sector has underperformed the market for many years now, but there are reasons to be optimistic. Click here for ...

Stock market crashes are scary, but they've always been followed by longer recovery periods. Intuitive Surgical is a leading ...

BioCryst Pharmaceuticals, Inc. acquires Astria Therapeutics for ~$700M, aiming to bolster its HAE portfolio. Learn more about ...

These companies are investing heavily into their pipelines and the payoff for long-term investors can be substantial.

Recently, there have been concerns around the surge of fraudulent loans and private credit quality issues in the US.

CRMD, CELC, RANI, and RAPT are pushing aggressively to the upside on Monday. Here's what is driving these four biotech stocks ...

​This partnership builds on an earlier collaboration, which was launched between the two companies in 2022. As part of this ...

Over the past decade, pharmaceutical maker Pfizer ( PFE -0.53%) has severely lagged the market. Dividends reinvested aside, ...

Teva Pharmaceutical Industries Ltd. (TEVA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most ...

Fintel reports that on October 21, 2025, Citigroup initiated coverage of ACADIA Pharmaceuticals (NasdaqGS:ACAD) with a Buy ...

The pharmaceutical company has also earned approval for Wegovy in treating metabolic dysfunction-associated steatohepatitis ...

Aurobindo Pharma stock has shown a technical breakout from a symmetrical triangle pattern. However, it is trading below its long-term moving average. Experts suggest waiting for a close above Rs 1,150 ...